Glycoursodeoxycholic acid (Ursodeoxycholylglycine) (Synonyms: GUDCA, Ursodeoxycholyl Glycine) |
Catalog No.GC33687 |
Glycoursodeoxycholic acid (Ursodeoxycholylglycine), a acyl glycine and a bile acid-glycine conjugate, is a metabolite of ursodeoxycholic acid.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 64480-66-6
Sample solution is provided at 25 µL, 10mM.
Glycoursodeoxycholic acid, a acyl glycine and a bile acid-glycine conjugate, is a metabolite of ursodeoxycholic acid.In Vitro: The antioxidant compound glycoursodeoxycholic acid (GUDCA) fully abrogates UCB-induced cytochrome c oxidase inhibition and significantly prevents oxidative stress, metabolic alterations, and cell demise[1].GUDCA has shown therapeutic efficacy in neurodegenerative models and diseases. Increased cytosolic SOD1 inclusions were observed in 4 DIV NSC-34/hSOD1(G93A) cells together with decreased mitochondria viability, caspase-9 activation, and apoptosis[2]. Glycoursodeoxycholic acid shows preventive and restorative effects against unconjugated bilirubin -induced blood-brain barrier disruption and damage to human brain microvascular endothelial cells[3].
Average Rating: 5
(Based on Reviews and 9 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *